Status:

ACTIVE_NOT_RECRUITING

A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With Dipyridamole

Lead Sponsor:

Yunfeng Xia

Conditions:

Restless Leg Syndrome Due to Uraemia

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

PHASE3

Brief Summary

The purpose of this clinical trial is to determine whether dipyridamole can treat restless legs syndrome in patients with uremia. In addition, the safety of dipyridamole will also be evaluated. The ma...

Detailed Description

This study is a self-controlled study in which all participants received active drug treatment for 6 months. The efficacy and safety of dipyridamole were evaluated by comparing changes in relevant sca...

Eligibility Criteria

Inclusion

  • (1) Maintenance hemodialysis for ≥3 months;(2) Age between 18-75 years;(3) Diagnosed with Restless Legs Syndrome (RLS) according to IRLSSG standards with a score \>15;(4) Willing to cooperate with this study.

Exclusion

  • (1). Patients with other cerebrovascular, muscular, and movement system diseases affecting the assessment of RLS;(2). Patients with active bleeding, such as gastrointestinal bleeding or intracerebral hemorrhage;(3). Patients who have been on dipyridamole for a long time;(4). Patients who have taken other medications that may affect RLS in the last 3 weeks, such as dopamine agonists/antagonists, tricyclic antidepressants, lithium, etc.;(5). Patients with a history of psychosis;(6). Pregnant or breastfeeding women;(7). Patients who are allergic or intolerant to dipyridamole;(8). Patients who cannot or are unwilling to cooperate with this study.

Key Trial Info

Start Date :

July 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT07199504

Start Date

July 1 2025

End Date

December 31 2026

Last Update

October 7 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

First Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China, 400016